US Stock MarketDetailed Quotes

FHTX Foghorn Therapeutics

Watchlist
  • 9.640
  • +0.760+8.56%
Trading Sep 13 12:02 ET
533.37MMarket Cap-4994P/E (TTM)

Foghorn Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
23.02%6.89M
-4.88%5.05M
77.63%34.16M
37.88%5.77M
163.46%17.48M
24.70%5.6M
35.43%5.31M
1,357.77%19.23M
486.82%4.18M
16,080.49%6.63M
Operating revenue
23.02%6.89M
-4.88%5.05M
77.63%34.16M
37.88%5.77M
163.46%17.48M
24.70%5.6M
35.43%5.31M
1,357.77%19.23M
486.82%4.18M
16,080.49%6.63M
Cost of revenue
Gross profit
Operating expense
-17.34%31.12M
-13.93%33.24M
4.18%142.06M
-13.43%31.23M
-0.96%34.56M
11.79%37.65M
21.76%38.63M
33.62%136.37M
25.26%36.07M
32.66%34.89M
Selling and administrative expenses
-12.81%7.33M
-10.77%7.71M
5.29%32.37M
-10.68%7.02M
4.31%8.31M
9.05%8.4M
19.75%8.64M
41.51%30.75M
24.16%7.86M
37.14%7.97M
-General and administrative expense
-12.81%7.33M
-10.77%7.71M
5.29%32.37M
-10.68%7.02M
4.31%8.31M
9.05%8.4M
19.75%8.64M
41.51%30.75M
24.16%7.86M
37.14%7.97M
Research and development costs
-18.64%23.8M
-14.84%25.53M
3.85%109.69M
-14.19%24.21M
-2.51%26.25M
12.60%29.25M
22.35%29.99M
31.49%105.62M
25.58%28.21M
31.39%26.93M
Operating profit
24.39%-24.23M
15.38%-28.19M
7.88%-107.91M
20.16%-25.46M
39.56%-17.08M
-9.81%-32.05M
-19.83%-33.32M
-16.28%-117.14M
-13.55%-31.89M
-7.61%-28.26M
Net non-operating interest income expense
2.76%2.87M
-8.62%2.44M
91.63%10.88M
11.95%2.66M
49.70%2.75M
128.00%2.79M
1,035.74%2.67M
407.26%5.68M
202.33%2.38M
916.02%1.84M
Non-operating interest income
2.76%2.87M
-8.62%2.44M
91.63%10.88M
11.95%2.66M
49.70%2.75M
128.00%2.79M
1,035.74%2.67M
9,518.64%5.68M
225.32%2.38M
170.44%1.84M
Other net income (expense)
-326.83%-1.62M
2.64%739K
9.73%2.83M
8.65%678K
10.75%721K
9.54%712K
9.92%720K
104.60%2.58M
624K
651K
Special income (charges)
---2.4M
----
----
----
----
--0
----
----
----
----
-Less:Impairment of capital assets
--2.4M
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
9.97%783K
2.64%739K
9.73%2.83M
8.65%678K
10.75%721K
9.54%712K
9.92%720K
3.45%2.58M
--624K
--651K
Income before tax
19.50%-22.98M
16.41%-25.02M
13.48%-94.2M
23.42%-22.12M
47.20%-13.61M
-4.51%-28.55M
-11.20%-29.93M
-7.46%-108.88M
0.88%-28.89M
1.19%-25.77M
Income tax
0
0
4.23M
1.99M
738K
942K
560K
0
0
0
Net income
22.07%-22.98M
17.95%-25.02M
9.60%-98.43M
16.55%-24.11M
44.33%-14.35M
-7.96%-29.49M
-13.28%-30.49M
-7.46%-108.88M
0.88%-28.89M
1.19%-25.77M
Net income continuous Operations
22.07%-22.98M
17.95%-25.02M
9.60%-98.43M
16.55%-24.11M
44.33%-14.35M
-7.96%-29.49M
-13.28%-30.49M
-7.46%-108.88M
0.88%-28.89M
1.19%-25.77M
Minority interest income
Net income attributable to the parent company
22.07%-22.98M
17.95%-25.02M
9.60%-98.43M
16.55%-24.11M
44.33%-14.35M
-7.96%-29.49M
-13.28%-30.49M
-7.46%-108.88M
0.88%-28.89M
1.19%-25.77M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
22.07%-22.98M
17.95%-25.02M
9.60%-98.43M
16.55%-24.11M
44.33%-14.35M
-7.96%-29.49M
-13.28%-30.49M
-7.46%-108.88M
0.88%-28.89M
1.19%-25.77M
Basic earnings per share
35.71%-0.45
19.18%-0.59
10.69%-2.34
17.39%-0.57
45.16%-0.34
-6.06%-0.7
-12.31%-0.73
4.03%-2.62
10.39%-0.69
12.68%-0.62
Diluted earnings per share
35.71%-0.45
19.18%-0.59
10.69%-2.34
17.39%-0.57
45.16%-0.34
-6.06%-0.7
-12.31%-0.73
4.03%-2.62
10.39%-0.69
12.68%-0.62
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 23.02%6.89M-4.88%5.05M77.63%34.16M37.88%5.77M163.46%17.48M24.70%5.6M35.43%5.31M1,357.77%19.23M486.82%4.18M16,080.49%6.63M
Operating revenue 23.02%6.89M-4.88%5.05M77.63%34.16M37.88%5.77M163.46%17.48M24.70%5.6M35.43%5.31M1,357.77%19.23M486.82%4.18M16,080.49%6.63M
Cost of revenue
Gross profit
Operating expense -17.34%31.12M-13.93%33.24M4.18%142.06M-13.43%31.23M-0.96%34.56M11.79%37.65M21.76%38.63M33.62%136.37M25.26%36.07M32.66%34.89M
Selling and administrative expenses -12.81%7.33M-10.77%7.71M5.29%32.37M-10.68%7.02M4.31%8.31M9.05%8.4M19.75%8.64M41.51%30.75M24.16%7.86M37.14%7.97M
-General and administrative expense -12.81%7.33M-10.77%7.71M5.29%32.37M-10.68%7.02M4.31%8.31M9.05%8.4M19.75%8.64M41.51%30.75M24.16%7.86M37.14%7.97M
Research and development costs -18.64%23.8M-14.84%25.53M3.85%109.69M-14.19%24.21M-2.51%26.25M12.60%29.25M22.35%29.99M31.49%105.62M25.58%28.21M31.39%26.93M
Operating profit 24.39%-24.23M15.38%-28.19M7.88%-107.91M20.16%-25.46M39.56%-17.08M-9.81%-32.05M-19.83%-33.32M-16.28%-117.14M-13.55%-31.89M-7.61%-28.26M
Net non-operating interest income expense 2.76%2.87M-8.62%2.44M91.63%10.88M11.95%2.66M49.70%2.75M128.00%2.79M1,035.74%2.67M407.26%5.68M202.33%2.38M916.02%1.84M
Non-operating interest income 2.76%2.87M-8.62%2.44M91.63%10.88M11.95%2.66M49.70%2.75M128.00%2.79M1,035.74%2.67M9,518.64%5.68M225.32%2.38M170.44%1.84M
Other net income (expense) -326.83%-1.62M2.64%739K9.73%2.83M8.65%678K10.75%721K9.54%712K9.92%720K104.60%2.58M624K651K
Special income (charges) ---2.4M------------------0----------------
-Less:Impairment of capital assets --2.4M------------------0----------------
Other non- operating income (expenses) 9.97%783K2.64%739K9.73%2.83M8.65%678K10.75%721K9.54%712K9.92%720K3.45%2.58M--624K--651K
Income before tax 19.50%-22.98M16.41%-25.02M13.48%-94.2M23.42%-22.12M47.20%-13.61M-4.51%-28.55M-11.20%-29.93M-7.46%-108.88M0.88%-28.89M1.19%-25.77M
Income tax 004.23M1.99M738K942K560K000
Net income 22.07%-22.98M17.95%-25.02M9.60%-98.43M16.55%-24.11M44.33%-14.35M-7.96%-29.49M-13.28%-30.49M-7.46%-108.88M0.88%-28.89M1.19%-25.77M
Net income continuous Operations 22.07%-22.98M17.95%-25.02M9.60%-98.43M16.55%-24.11M44.33%-14.35M-7.96%-29.49M-13.28%-30.49M-7.46%-108.88M0.88%-28.89M1.19%-25.77M
Minority interest income
Net income attributable to the parent company 22.07%-22.98M17.95%-25.02M9.60%-98.43M16.55%-24.11M44.33%-14.35M-7.96%-29.49M-13.28%-30.49M-7.46%-108.88M0.88%-28.89M1.19%-25.77M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 22.07%-22.98M17.95%-25.02M9.60%-98.43M16.55%-24.11M44.33%-14.35M-7.96%-29.49M-13.28%-30.49M-7.46%-108.88M0.88%-28.89M1.19%-25.77M
Basic earnings per share 35.71%-0.4519.18%-0.5910.69%-2.3417.39%-0.5745.16%-0.34-6.06%-0.7-12.31%-0.734.03%-2.6210.39%-0.6912.68%-0.62
Diluted earnings per share 35.71%-0.4519.18%-0.5910.69%-2.3417.39%-0.5745.16%-0.34-6.06%-0.7-12.31%-0.734.03%-2.6210.39%-0.6912.68%-0.62
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data